Similarly, we also detected the PI3K activator IGF-1, although the tumor volume in the Cis+FJD-H+IGF-1 group mice was still higher than that in the model group, but it also hindered the tumor inhibitory effect of the Cis+FJD-H group as expected. This evidence concerns the gene IGF1 and neoplasm.